Chemical leaks and fires have taken place at numerous hospitals across the country, an investigation by a British political party has found.
Category: Forbes
InnovationRx: 70% Of U.S. Adults ‘Concerned’ About AI In Healthcare
InnovationRx is your weekly digest of healthcare news. Sign up!
A Roadmap To Health Equity: Addressing The Conditions Of Our Environment That Affect Our Health
We need to redraw the map toward equitable health and well-being in our post-pandemic lives because COVID-19 is here to stay.
Long Covid May Affect Organs Like The Heart And Kidneys After Lungs Recover, New Research Says
Over 65 million worldwide are affected by long Covid, which can linger for up to years.
The RATIONS Trial: Food Supplements Are Transforming TB Survival In India
Treating malnutrition markedly reduces deaths in TB patients in India. It’s cheaper, too, than antibiotics and doesn’t promote antibiotic resistance. What’s stopping us?
Digital Health Company Babylon Shutters U.S. Business, Lays Off Employees
The troubled virtual care firm, which has been looking for a buyer, told the Texas Workforce Commission it would “permanently close” its Austin headquarters as of August 7.
In-Ear Bioelectronic May Replace Leading Brain-Computer Implants
In the coming years, a new in-ear bioelectronic called SpiralE may be the next step toward seamless brain-computer interfaces.
Biden Administration Will Reportedly Launch System To Track Heat-Related Illness Nationwide
After a summer of many U.S. cities breaking their heat record, the Biden administration is taking a step towards acknowledging the effects of extreme heat—creating a n…
Topline Data On Obesity Drug Wegovy’s Impact On Cardiovascular Outcomes Won’t Necessarily Change Payer Coverage Policies
Topline data from the SELECT trial look good. But this may not necessarily change payer coverage policies on weight loss agents, at least not in the short term.
$6.16 Billion Per Drug Approval: Almost Half of Big Pharma Companies Hit Negative R&D Productivity
New study by the St Gallen consortium estimates the cost of one approved drug at $6.16 Billion. 7 of the top 16 pharma companies demonstrated negative R&D productivity.
